Phase 2 Prostate Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• The person must be male and aged 21 years or older.
• The person must be able to understand and sign a consent form, and be willing to follow the study's requirements.
• The person must have a confirmed diagnosis of prostate cancer that falls into one of these categories: high-risk prostate cancer (based on specific pathology scores, a PSA level of 20 or higher, or a certain tumour stage), or a specific type of intermediate-risk prostate cancer with certain unfavourable features (confirm with trial site for exact details).
• The person must agree to use an acceptable form of birth control and wear condoms for seven days after each PSMA injection, if sexually active.
• There must be no sign that the cancer has spread to other parts of the body, including nearby lymph nodes.

Who may not be able to join:

• People with clinical or technical factors that could interfere with the accuracy of the PET or MRI scans used in the study.
• People who have medical reasons that prevent them from safely receiving the PSMA injection used in the study.
• People who have medical reasons that prevent them from safely receiving a type of targeted radiation therapy to the prostate — this includes people who have previously had a certain prostate surgery (transurethral resection), have a prostate larger than 150cc, have a urinary symptom score above 20, or have had prior radiation to the prostate.
• People who, in the opinion of the research team, are considered unsuitable for the trial for any other reason.
• People who are currently taking, or planning to take, a medication called abiraterone.

Important: Always verify eligibility with the trial site directly before applying.